A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
about
Enhanced Efficacy without Further Cleft Closure: Reevaluating Twist as a Source of Agonist Efficacy in AMPA ReceptorsOn the mechanisms of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate.Not all desensitizations are created equal: physiological evidence that AMPA receptor desensitization differs for kainate and glutamate.Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.Retour aux sources: defining the structural basis of glutamate receptor activation.Glutamate receptors at atomic resolution.NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.A quantum biochemistry investigation of willardiine partial agonism in AMPA receptors.The role of the local environment of engineered Tyr to Trp substitutions for probing the denaturation mechanism of FIS.Quantifying water-mediated protein-ligand interactions in a glutamate receptor: a DFT study.GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis.
P2860
Q27659250-9681EB6E-2AC3-43C7-82AD-CE4C26F38498Q33782625-984E1695-45B1-4BC3-943B-6FCF2D40434EQ35174855-46264BC4-5CDE-4E53-BE68-B4DEB34C4D8CQ36394958-020700F2-B127-457C-8EBB-91D88A50FD56Q36408217-14B4864C-A1BD-467F-8EA7-E402632399C2Q38306583-AE8BF9A2-3E50-42F4-9E5A-8C142BBCE853Q40340618-BA062582-419D-40CA-97EB-B0C2CC290C06Q40373782-74F830C0-4D1C-482C-878D-6E6743DAF5BCQ41010244-610050E0-E5B4-41B1-94D1-1BADB82F1125Q42649845-B0CC15BB-5D4A-4B3A-B0D3-BBE728321FEFQ42739559-A3F71851-9887-43CC-9E32-C573DE70129AQ46097376-0B43A190-F3C4-408A-93CD-6E4ED42F6D66
P2860
A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A binding site tyrosine shapes ...... c, and crystallographic study.
@en
A binding site tyrosine shapes ...... c, and crystallographic study.
@nl
type
label
A binding site tyrosine shapes ...... c, and crystallographic study.
@en
A binding site tyrosine shapes ...... c, and crystallographic study.
@nl
prefLabel
A binding site tyrosine shapes ...... c, and crystallographic study.
@en
A binding site tyrosine shapes ...... c, and crystallographic study.
@nl
P2093
P2860
P50
P356
P1476
A binding site tyrosine shapes ...... c, and crystallographic study.
@en
P2093
Jan Egebjerg
Mai Marie Holm
Matthew T Geballe
Peter Naur
Stephen F Traynelis
P2860
P304
35469-35476
P356
10.1074/JBC.M507800200
P407
P577
2005-08-15T00:00:00Z